Image

Global Tumor Ablation Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Tumor Ablation Market, By Type (Tumor Ablation Systems, Image Guidance Products and Accessories), Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer and Others), Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation and Other Technologies), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation and Surgical Ablation), End User (Hospitals, Oncology Clinics and Others) – Industry Trends and Forecast to 2029

Tumor Ablation Market

Global Tumor Ablation Market Analysis and Size

The market for tumor ablation is estimated to increase rapidly over the forecast period owing to high cancer prevalence rate. By 2030, the World Health Organization estimates that 10-11 million cancer cases will be diagnosed annually over the world. Between 2008 and 2030, the number of new cancer cases in low-income countries is expected to increase by more than 80%, compared to 40% in high-income countries. Lucrative growth potential in currently existing therapeutic alternatives and growing demand for minimally and non-invasive therapies will led to the high demand of tumor ablation in the market.

  • Data Bridge Market Research analyses that the tumor ablation market was valued at USD 580.1 million in 2021 and is expected to reach USD 1,591.9 million by 2029, registering a CAGR of 13.45% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Tumor Ablation Market Definition

Tumor ablation is a minimally invasive (MI) procedure used to treat malignancies in the kidney, liver, bones, and lungs. The ablation system is made up of a generator and a needle-like device that delivers heat directly to the target cells, resulting in severe cellular necrosis. The method kills benign tumors without removing them from the body by inserting a probe and heating it to 100 degrees Celsius under Precise Computer Tomography. Microwave ablation, radiofrequency ablation, cryoablation, and other methods can be used. It offers better accuracy and a larger treatment area and low pain and risk to the patient when used repeatedly.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Tumor Ablation Systems, Image Guidance Products and Accessories), Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer and Others), Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation and Other Technologies), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation and Surgical Ablation), End User (Hospitals, Oncology Clinics and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

AngioDynamics (US), Medtronic (Ireland), Boston Scientific Corporation (US), BIOTRONIK SE & Co KG (Germany), EDAP TMS (France), HealthTronics, Inc. (US), Misonix (US), Medical Devices Business Services, Inc. (US), Sonacare Medical (NC), Erbe Elektromedizin GmbH (Germany), MERMAID MEDICAL A/S (Denmark), BTG International Ltd (UK), BVM Medical Limited (UK), COMSOL INC. (Sweden), Cortex Technology (Denmark), CooperSurgical, Inc. (US), AtriCure, Inc (US), Abbott (US), Integra LifeSciences (US), Smith+Nephew (UK), CONMED Corporation (US)

Market Opportunities

 

  • Increase in the number of emerging markets
  • Increasing awareness about ablation procedures over conventional therapeutics
  • New product launches

Tumor Ablation Market Dynamics

Drivers

  • Technological advancement in ablation devices 

One of the important factors driving the market is the rising technological advancement in ablation devices. The introduction of thermal and laser ablation, irreversible electroporation, and High-Intensity Focused Ultrasound (HIFU) have all helped to increase the acceptance of tumor ablation methods.

  • Rising preference towards minimally invasive procedures

The increasing preference of surgeons and patients towards minimally invasive procedures will cushion the growth rate of tumor ablation market. Various benefits are associated with these procedures including speed recovery, reduced turnaround time, patient comfort and others.

Furthermore, the increase in the prevalence of cancer is expected to boost market growth. The rising number of geriatric population across the globe and sedentary lifestyle are projected to contribute to the market's growth. Other significant factors such as the implementation of favourable government policies for cancer awareness and treatment methods will cushion the growth rate of tumor ablation market. The growing level of healthcare expenditure will expand the growth rate of tumor ablation market

Opportunities

  • Growing awareness about ablation procedures

Increasing awareness about ablation procedures over conventional therapeutics and surgical procedures is expected to propel the global tumor ablation market forward and will provide beneficial opportunities for the tumor ablation market growth.

Moreover, increase in the number of emerging markets and upsurge in number of new product launched are boosting plenty of beneficial opportunities that will propel the tumor ablation market forward over the projection period.

Restraints/Challenges Global Tumor Ablation Market

  • Side effects associated with ablation treatment

Side effects associated with ablation treatment such as infection in the liver, abdominal pain, bleeding into chest cavity or abdomen and others will impede the market’s growth rate.

However, strict government regulations and high costs associated with treatment are expected to hinder the growth of the tumor ablation market. Also, severe impact of COVID-19 outbreak on supply chain and lack of awareness will act as a challenge that could stymie the tumor ablation market's growth.

This tumor ablation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tumor ablation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Tumor Ablation Market

Cancer is one of the world's most feared diseases, having claimed the lives of many loved ones all over the world. Since the novel coronavirus was labelled a public health emergency and a pandemic, it has taken a toll on people's lives and diverted medical experts' and healthcare providers' attention to treating COVID-19-positive patients.

COVID-19 and the related deferral of medical operations have had a detrimental influence on the medical devices market, according to prominent manufacturers, in the first half of 2020. Furthermore, as the COVID-19 outbreak continues to harm the US and global economies, the global regulatory landscape has been impacted. To deal with the pandemic's issues, the US FDA and other health authorities have changed their resources and priorities to deal with it. These pandemic-related disruptions have had a little detrimental influence on the processing of regulatory submissions, as well as the time it takes for agencies to assess new products for approval.

Recent Development

  • In April 2021, Medtronic plc had received breakthrough Device Designation status from U.S. Food and Drug Administration (FDA) for Emprint ablation catheter kit. The FDA Breakthrough Device Program aims to provide patient access to breakthrough technologies that have the potential to improve therapy or diagnosis for life-threatening or irreversibly debilitating diseases and disorders.

Global Tumor Ablation Market Scope

The tumor ablation market is segmented on the basis of type, component, deployment mode and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Tumor Ablation Systems
  • Image Guidance Products
  • Accessories

On the basis of type, the tumor ablation market is segmented into tumor ablation systems, image guidance products and accessories.

Cancer Type

  • Liver Cancer
  • Brain Cancer
  • Lung Cancer
  • Bone Cancer
  • Kidney Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Others

On the basis of cancer type, the tumor ablation market is segmented into liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer and others.

Technology

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technologies

On the basis of technology, the tumor ablation market is segmented into radiofrequency ablation, microwave ablation, cryoablation and other technologies.

Mode of Treatment

  • Percutaneous Ablation
  • Laparoscopic Ablation
  • Surgical Ablation

On the basis of mode of treatment, the tumor ablation market is segmented into percutaneous ablation, laparoscopic ablation, and surgical ablation.

End User

  • Hospitals
  • Oncology Clinics
  • Others

On the basis of end user, the tumor ablation market is segmented into hospitals, oncology clinics, and others.

Tumor Ablation Market Regional Analysis/Insights

The tumor ablation market is analysed and market size insights and trends are provided by country, type, cancer type, technology, mode of treatment and end user as referenced above.

The countries covered in the tumor ablation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the tumor ablation market because of the increasing government support for quality healthcare in this region. Additionally, a rise in parity's purchasing power will flourish the market’s growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to rising patient population and emergence of major healthcare providers in rapidly advancing countries in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The tumor ablation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tumor ablation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tumor ablation market. The data is available for historic period 2010-2020.

Competitive Landscape and Tumor Ablation Market Share Analysis

The Tumor ablation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tumor ablation market.

Some of the major players operating in the tumor ablation market are:

  • AngioDynamics (US)
  • Medtronic (Ireland)
  • Boston Scientific Corporation (US)
  • BIOTRONIK SE & Co KG (Germany)
  • EDAP TMS (France)
  • HealthTronics, Inc. (US)
  • Misonix (US)
  • Medical Devices Business Services, Inc. (US)
  • Sonacare Medical (NC)
  • Erbe Elektromedizin GmbH (Germany)
  • MERMAID MEDICAL A/S (Denmark)
  • BTG International Ltd (UK)
  • BVM Medical Limited (UK)
  • COMSOL INC. (Sweden)
  • Cortex Technology (Denmark)
  • CooperSurgical, Inc. (US)
  • AtriCure, Inc (US)
  • Abbott (US)
  • Integra LifeSciences (US)
  • Smith+Nephew (UK)
  • CONMED Corporation (US)

Research Methodology : Global Tumor Ablation Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-tumour-ablation-market

Customization Available : Global Tumor Ablation Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Market Value for Tumor Ablation Market in 2021 is expected USD 1,591.9 million by 2029.
The Tumor Ablation Market is to Grow at a CAGR of 13.45% During the Forecast Period of 2022 to 2029.
AngioDynamics (US), Medtronic (Ireland), Boston Scientific Corporation (US), BIOTRONIK SE & Co KG (Germany), EDAP TMS (France), Abbott (US), Integra LifeSciences (US), Smith+Nephew (UK), CONMED Corporation (US) are the major companies operating in Tumor Ablation Market.
The Countries Covered in the Tumor Ablation Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Tumor Ablation Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.